CDPE https://validator.w3.org/feed/docs/rss2.html About Investigating the spatial association between supervised consumption services and homicide rates in Toronto, Canada, 2010–2023: an ecological analysis Barriers and facilitators to safer supply pilot program implementation in Canada: a qualitative assessment of service provider perspectives Our Team A qualitative assessment of tablet injectable opioid agonist therapy (TiOAT) in rural and smaller urban British Columbia, Canada: Motivations and initial impacts T-DOT (Toronto Disparities, Overdose and Treatment) Police encounters among people who use drugs in Toronto, Canada Safer opioid supply clients’ values and preferences: a systematic review and thematic synthesis of qualitative research A Preliminary Assessment of Short-Term Social and Substance Use-Related Outcomes Among Clients of Integrated Safer Opioid Supply Pilot Programs in Toronto, Canada Home Cohort profile: the Kyrgyzstan InterSectional Stigma (KISS) injection drug use cohort study Financial Vulnerability and Its Association with HIV Transmission Risk Behaviors Among People Who Inject Drugs in Kyrgyzstan A cross-sectional assessment of injection of “salts” and HIV transmission-related behaviours among a cohort of people who inject drugs in Kyrgyzstan Towards a More Equitable Cannabis Industry in Ontario: Enabling an Inclusive, Diverse, and Vibrant Legal Market Recreational Cannabis Regulation & International Law: Scenarios for States Parties to the UN Drug Conventions New Policy Brief Provides Guidance to States on Aligning Regulation of Recreational Cannabis Markets With International Legal Obligations UN Green Lights Medicinal Cannabis, Fails to Challenge Colonial Legacy of its Prohibition Past Project: #CannabisClaims How Diverse is Canada’s Legal Cannabis Industry? Examining Race and Gender of its Executives and Directors Canada’s Legal Cannabis Industry Lacks Diversity, A New Policy Brief by the Centre on Drug Policy Evaluation and the University of Toronto Finds Policy Impact Unit A Roadmap for Cannabis Equity in Canada to Inform the Legislated Review of the Cannabis Act New Report Outlines Recommendations for Achieving Equity and Social Justice in Canadian Cannabis Policies Bracing for Fentanyl: NZ Experts Push for Safe Drug-using Space Toronto Star: Here’s what happened to overdose deaths in Toronto neighbourhoods with safe consumption sites Healthy Debate: Involuntary drug treatment: ‘Compassionate intervention’ or policy dead end? Hundreds of Kilograms of Drugs Seized in Three-Month Investigation Raise Questions on Market Impact A huge development for DoseCheck: Q&A with Dr. Dan Werb Significance of Safe Consumption Sites in Reducing Overdose Deaths Summer Impacts on Canada’s Opioid Crisis Ford Cracks Down on Supervised Consumption Sites Changing supply one reason for declining opioid deaths, analysis shows The Centre on Drug Policy Evaluation’s Statement on the Closure of Supervised Consumption Sites Opinion | Digging into the numbers behind Toronto’s recent drop in opioid deaths Toronto is seeing a drop in opioid overdose deaths. Here’s why Experts did not recommend closing Leslieville drug consumption site Ontario’s closure of 10 drug consumption sites defies expert advice Opioid deaths in Canada fell 17% in 2024, but thousands are still dying Is peer-review dead? A scientist’s plea to fix a broken system Brooklyn McNeil Rae of Hope Award 2025 ISSDP Excellence in Research Award Winner: Indhu Rammohan CIHR 2025 Trailblazer Award Winner: Dr. Mohammad Karamouzian Safer Opioid Supply Programs Evaluation in Toronto, Ontario Reduced risk of overdose among clients of a safer opioid supply program in Southwestern Ontario: A pre-post observational cohort study A scoping review and concept analysis to inform Canada’s safe(r) opioid supply research agenda Beyond encampments: an evidence-based path to solving Canada’s homelessness crisis DoseCheck The rise and fall of carfentanil in Toronto’s unregulated drug supply Piloting and Evaluating Drug Checking Services in Toronto, Ontario PATH-Toronto (Promoting Access to Treatment for Toronto’s Homeless Youth in Substance Use and Mental Health)